Document is current
Any future updates will be listed below
-
Authors
Gielis, Sofie
Flumens, Donovan
van der Heijden, Sanne
Versteven, Maarten
De Reu, Hans
Bartholomeus, Esther
Schippers, Jolien
Campillo-Davo, Diana
Berneman, Zwi N.
Anguille, Sébastien
Smits, Evelien
Ogunjimi, Benson
Lion, Eva
Laukens, Kris
Meysman, Pieter
-
Funding
Funding for this research was provided by:
Stichting ME TO YOU
Fonds Wetenschappelijk Onderzoek (1S48819N, 1S24517N, 1861219N)
Baillet Latour Fund (‘‘Cellular Immunotherapy’’ grant)
Kom op tegen Kanker (Emmanuel van der Schueren fellowship)
Universiteit Antwerpen (DOCPRO PhD grant of the Special Research Fund, BOF-KP2018)
- License Information
-
More Information
Article History
Received: 14 March 2024
Accepted: 26 July 2024
First Online: 11 September 2024
Declarations
:
: The use of human samples in this study was approved by the Ethics Committee of the Antwerp University Hospital and the University of Antwerp under reference number 15/19/210.
: Not applicable.
: K.L., P.M. and B.O. hold shares in ImmuneWatch BV, an immunoinformatics company.
